Skip to content

AXONE PHARMA

Active
Boulevard de France 9 ·1420 Braine-l'Alleud, Belgium
KBO/BCE: BE 0830.551.216
Watch Print / PDF
Age15 yrs
Board3
Connections8
Real estate2 parcels · 2.4 ha

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of AXONE PHARMA is 0.7% (low). The company has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Based on State Gazette and CBE data.

Trust signals

2 signals
Established
Founded in 2010, 15 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No administrative flags

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.7% Low
0%0,5%1,5%4%10%≥25%
Multiple establishment units +Lower-risk legal form −Higher-failure-rate sector +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

Annual accounts & ratios

Source: NBB
Financials being processed
NBB has 10 filing(s) on record for this company, latest fiscal year 2025 (volledig). The annual accounts are being processed.
Filings on record
Fiscal year Type Filed Reference
31-12-2025 volledig 05-06-2026 2026-00145214
31-12-2024 volledig 26-06-2025 2025-00180233
31-12-2023 volledig 08-07-2024 2024-00218573
31-12-2022 volledig 28-06-2023 2023-00166970
31-12-2021 volledig 30-06-2022 2022-20109750
31-12-2020 volledig 16-06-2021 2021-20100381
31-12-2019 volledig 27-05-2020 2020-13200395
31-12-2018 volledig 11-09-2019 2019-63900031
31-12-2017 volledig 16-07-2018 2018-32700354
31-12-2016 volledig 29-06-2017 2017-24600186

Directors

Directors & mandates

under verification
Directors derived from a single State Gazette act, under verification
All 3 current directors first appear in the same act (25002722). Founders or capital subscribers may have been counted as directors here; the real board composition is being verified.
Current directors & mandates
  • Suru ConsultLegal entity
    Director· perm. rep.: Ruben Suply
    State Gazette act 25002722 (07-01-2025)
    Current
    01-01-2024 → present
    2 events
    • 01-01-2024 Appointed· Director
    • 01-01-2024 Appointed· Managing director
  • ALEXOLegal entity
    Director· perm. rep.: Olivier Delaere
    State Gazette act 25002722 (07-01-2025)
    Current
    01-05-2022 → present
  • ARISTOLegal entity
    Director· perm. rep.: Frank Coene
    State Gazette act 25002722 (07-01-2025)
    Current
    08-12-2020 → present
    3 events
    • 01-05-2022 Mandate renewed· Director
    • 01-05-2022 Appointed· Director
    • 08-12-2020 Appointed· Director
Historic, not recently confirmed (2)
These mandates remain open in the register but have not been confirmed by a new act in over six years. They do not count as active directors.
  • AlexoLegal entity
    Director· perm. rep.: Olivier Delaere
    State Gazette act 16174127 (20-12-2016)
    Not recently confirmed
    last confirmed in an act from 2016
  • BVBA AlexoLegal entity
    Director· perm. rep.: Olivier Delaere
    State Gazette act 11056672 (14-04-2011)
    Not recently confirmed
    last confirmed in an act from 2011
    2 events
    • 14-04-2011 Appointed· Director
    • 14-04-2011 Appointed· Managing director
Former directors (3)
  • Ruben Suply
    Director
    State Gazette act 21034800 (18-03-2021)
    Former
    08-12-2020 → 01-01-2024
    2 events
    • 01-01-2024 Resigned· Director
    • 08-12-2020 Appointed· Director
  • Eric Van Nueten
    Director
    State Gazette act 16174127 (20-12-2016)
    Former
    14-04-2011 → 01-12-2020
    4 events
    • 01-12-2020 Resigned· Director
    • 20-12-2016 Appointed· Director
    • 14-04-2011 Appointed· Director
    • 14-04-2011 Appointed· Managing director
  • Frank Coene
    Director
    State Gazette act 16174127 (20-12-2016)
    Former
    14-04-2011 → 01-12-2020
    5 events
    • 01-12-2020 Resigned· Director
    • 20-12-2016 Appointed· Director
    • 14-04-2011 Appointed· Director
    • 14-04-2011 Appointed· Managing director
    • 14-04-2011 Resigned· Director
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.

Statutory auditor

3 auditors
Statutory auditor IRE/IBR number Tenure
Moore AuditCurrent
Statutory auditor · represented by Koen van Eupen
 - 01-05-2022 → present
SCRL Moore Stephens Audit
Statutory auditor · represented by Koen van Eupen
succeeded by Moore Audit in 2022
 - 24-12-2019 → 01-05-2022
Verschelden - Walkiers & Co, Réviseurs d'entreprises S.C.R.L.
Statutory auditor · represented by Eric Vandenhouten
succeeded by SCRL Moore Stephens Audit in 2019
 - 10-06-2013 → 24-12-2019
Appointed statutory auditor from the Belgian State Gazette. The IRE/IBR number refers to the register of the Institute of Registered Auditors.

Insolvency mandates

No insolvency mandates (liquidators, administrators) on record for this company.

Legal Structure

NACE primary Handelsbemiddeling in de groothandel in andere specifieke goederen(46180)
Legal form Public limited company(014)
Incorporation22-10-2010
StatusActive
Postal code1420

Structure & network

Connections & network

8 connected companies
ALEXO, Parent company AALEXOARISTO, Parent company AARISTOMoore Audit, Parent company MAMoore AuditSuru Consult, Parent company SCSuru ConsultFEBELFARMA, Shared corporate director FFEBELFARMAMedista, Shared corporate director MMedistaMIRO INVEST, Shared corporate director MIMIRO INVESTRAAL LA LOUVIERE, Shared corporate director RLRAAL LALOUVIEREAXONE PHARMA AXONE PHARMA0830.551.216
Group structureShared directors
Group structure
ALEXO
Parent · 4 subsidiaries · 1 location
Control→
ARISTO
Parent · 3 subsidiaries · 1 location
Control→
Moore Audit
Parent · 418 subsidiaries · 9 locations
Control→
Suru Consult
Parent · 1 subsidiary · 1 location
Control→
Network connections
FEBELFARMA
Shared corporate director
→
Medista
Shared corporate director
→
MIRO INVEST
Shared corporate director
→
RAAL LA LOUVIERE
Shared corporate director
→
Connections derived from shared directors, addresses, shareholders and group structure in the Belgian State Gazette.

Locations & real estate

Establishment units

2 locations
Axona Pharma
Boulevard de France 9, 1420 Braine-l'AlleudHandelsbemiddeling in farmaceutische producten en orthopedische artikelen
since 20102.192.765.172
Axone Pharma
Avenue de Finlande 8, 1420 Braine-l'AlleudHandelsbemiddeling in farmaceutische producten en orthopedische artikelen
since 20252.368.406.042
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels2
Ground area2.4 ha
Buildings2
Building footprint4,195 m²
Volume (LiDAR)86,924 m³
Tallest building28.7 m · ±7 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Wallonia 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
25744D0293/00T003 Wallonia 1.6 ha 1 · 3,334 m² 28.7 m · 7 fl.
25744D0293/00R003 Wallonia 7,876 m² 1 · 860 m² 17.9 m · 5 fl.
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgian State Gazette · acts

1 verified act

What every Belgian State Gazette publication actually says, each act broken down into appointments, capital movements, seat moves and statute amendments.

2026
05-08-2026 General meeting · Director resignation · Director appointment
7 facts
  • General meeting , 19/05/2026
  • Director resignation, SRL ALEXO (administrateur)
  • Director appointment, SRL KST Pharma (administrateur)
  • Permanent representative, Olivier Delaere
  • Permanent representative, Koen Straetmans
  • Permanent representative, Frank Coene
+1 further fact

Analysis

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Same sector, nearest first

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Handelsbemiddeling gespecialiseerd in andere goederen46180Handelsbemiddeling in de groothandel in andere specifieke goederen46180Groothandel in farmaceutische producten46460Groothandel in farmaceutische en medische artikelen46460Groothandel in farmaceutische producten46460Groothandel in farmaceutische en medische artikelen46460
Primary activity highlighted.
Names & trade names
Legal nameFR AXONE PHARMA
Registered office
Boulevard de France 9 bus A
1420 Braine-l'Alleud, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.